Loading…
CRS Fall 2016 has ended
Back To Schedule
Saturday, October 15 • 2:15pm - 3:15pm
Meeting Quality Measures and Improving Outcomes in Heart Failure Patients with Comorbidities: Where Do New Therapies Fit?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
This activity is supported by an educational funding donation provided by Amgen and an educational grant from Novartis Pharmaceuticals Corporation.

The interrelationships of pathophysiology in heart failure (HF) and metabolic syndrome will be discussed in this session. In addition, Dr. Blount will assess how current HF therapies can be used synergistically in the treatment of patients with comorbid metabolic syndrome, and evaluate the efficacy and safety of newly approved therapies for treating patients with HF.
Speakers
avatar for B. Wayne Blount, MD, MPH

B. Wayne Blount, MD, MPH

Adjunct Professor, Emory School of Medicine; Medical Director, JenCare; Bartow, Florida
Dr. Wayne Blount is an accomplished, deeply caring family physician whose extensive military service, medical expertise and compassion for humankind have helped bring knowledge and healing to the world. "I have always had a desire to help others," he says. "I enjoy meeting people... Read More →

Saturday October 15, 2016 2:15pm - 3:15pm PDT
Caesars Palace, Las Vegas
  Core Cardiometabolic Session

Attendees (17)